LU82025A1 - Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere - Google Patents

Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere Download PDF

Info

Publication number
LU82025A1
LU82025A1 LU82025A LU82025A LU82025A1 LU 82025 A1 LU82025 A1 LU 82025A1 LU 82025 A LU82025 A LU 82025A LU 82025 A LU82025 A LU 82025A LU 82025 A1 LU82025 A1 LU 82025A1
Authority
LU
Luxembourg
Prior art keywords
polymer
cardiac
preparation
pharmaceutical
soluble
Prior art date
Application number
LU82025A
Other languages
English (en)
French (fr)
Inventor
C Appelgren
C Bogentoft
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of LU82025A1 publication Critical patent/LU82025A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/3278—Apparatus for destroying used needles or syringes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Crushing And Grinding (AREA)
  • Disintegrating Or Milling (AREA)
LU82025A 1978-12-05 1979-12-21 Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere LU82025A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPD700478 1978-12-05
AUPD700478 1978-12-05
SE7813245A SE426548B (sv) 1978-12-05 1978-12-22 Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
SE7813245 1978-12-22

Publications (1)

Publication Number Publication Date
LU82025A1 true LU82025A1 (fr) 1980-07-21

Family

ID=25642273

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82025A LU82025A1 (fr) 1978-12-05 1979-12-21 Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere

Country Status (14)

Country Link
US (1) US4261971A (xx)
EP (1) EP0013263B1 (xx)
JP (2) JPS55102443A (xx)
AU (1) AU531279B2 (xx)
BE (1) BE880796A (xx)
CA (1) CA1133394A (xx)
CH (1) CH641358A5 (xx)
DE (1) DE2948632A1 (xx)
DK (1) DK542379A (xx)
FI (1) FI794006A (xx)
GB (1) GB2044619A (xx)
LU (1) LU82025A1 (xx)
SE (1) SE426548B (xx)
ZA (2) ZA796606B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
JPS5769913A (en) * 1980-10-20 1982-04-30 Toshiba Corp Input buffer circuit for measuring device
DE3264867D1 (en) * 1981-04-27 1985-08-29 Haessle Ab New pharmaceutical preparation
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
IE55519B1 (en) * 1982-05-14 1990-10-10 Maroko Peter R Use of a protoberberine alkaloid and composition containing same
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
DE3632092A1 (de) * 1986-09-20 1988-03-24 Hans Bauer Entsorgungssystem fuer kanuelen
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
US4996113A (en) * 1989-04-24 1991-02-26 Aluminum Company Of America Brightness enhancement with textured roll
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
TW212139B (xx) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
GB2321597B (en) * 1997-01-29 2000-01-26 Elizabeth Margaret Rinfret Syringe needle disposal device
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
WO2007089688A2 (en) * 2006-01-31 2007-08-09 The University Of Toledo Na/k-atpase ligand
CN101541319B (zh) 2006-10-31 2013-09-18 托莱多大学 Src和Src家族激酶的Na+/K+-ATP酶特异性肽抑制剂/激活剂
CA2615137A1 (en) * 2007-12-17 2009-06-17 Pharmascience Inc. Single layered controlled release therapeutic system
CA2774486C (en) 2009-09-16 2019-06-04 The University Of Toledo Hydroxy xanthone-based na/k atpase ligands useful in treating cardiac hypertrophy, and congestive heart failure
US8835171B2 (en) 2010-01-13 2014-09-16 The University Of Toledo Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2455790A (en) * 1945-06-09 1948-12-07 Eastman Kodak Co Enteric coatings
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
GB742544A (en) * 1952-02-23 1955-12-30 Kodak Ltd Enteric products
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
IT629516A (xx) * 1959-04-30
NL270408A (xx) * 1960-10-20
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
NL297631A (xx) * 1963-06-03
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
GB1276089A (en) * 1968-08-23 1972-06-01 Pfizer Ltd Pharmaceutical preparations
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
IL42166A (en) * 1973-05-02 1976-01-30 Res Prod Rehovot Ltd Drug releasing preparation
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
SE418247B (sv) 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof

Also Published As

Publication number Publication date
AU531279B2 (en) 1983-08-18
JPS5587717A (en) 1980-07-02
DK542379A (da) 1980-06-23
EP0013263A2 (en) 1980-07-09
SE426548B (sv) 1983-01-31
CH641358A5 (de) 1984-02-29
AU5396279A (en) 1980-06-26
ZA796683B (en) 1980-11-26
BE880796A (fr) 1980-06-23
EP0013263B1 (en) 1983-08-03
CA1133394A (en) 1982-10-12
FI794006A (fi) 1980-06-23
DE2948632A1 (de) 1980-06-19
SE7813245L (sv) 1980-06-23
ZA796606B (en) 1980-12-31
GB2044619A (en) 1980-10-22
US4261971A (en) 1981-04-14
EP0013263A3 (en) 1981-05-27
JPS55102443A (en) 1980-08-05

Similar Documents

Publication Publication Date Title
LU82025A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere
LU82026A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere
DE69934505T2 (de) Im munde zerfallende tablette enthaltend ein benzimidazole
WO2013027150A1 (en) Compositions and methods for the treatment of parkinson's disease
EP2018158B1 (fr) Nouvelle forme d'administration du racecadotril
KR20120107533A (ko) ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
JP2004506657A (ja) 天然および合成ｈｃａのバイオアベイラブルな組成物
WO2012022919A2 (fr) Formulations à base de nalbuphine et leurs utilisations
US11717501B2 (en) Magnesium threonate compositions and uses thereof
EP2307405B1 (en) Composition of flavanolignan and amino acid with improved water solubility
EP1827136B1 (en) Formulation for oral administration having a health-promoting effect on the cardiovascular system
EP1646379A2 (fr) Nouvelle composition pharmaceutique solide comprenant de l a misulpride
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
US20080182787A1 (en) Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues
BE1010972A6 (fr) Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition.
CN113384541B (zh) 一种用于防治早期神经退行性疾病的鼻腔纳米自噬诱导剂及其制备方法
US20150209309A1 (en) Naca for the treatment of chronic or acute cognitive dysfunction
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
WO2007132328A2 (fr) Nouvelles formes galéniques de l'artemisinine et ses dérives en association avec d'autres antipaludéens pour le traitement de la malaria
LU85976A1 (fr) Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique
EP0483320B1 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation
LU84062A1 (fr) Esters de mercaptoacyl-carnitines,procede pour leur preparation et leurs utilisations therapeutiques,notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
US20150209310A1 (en) Naca for the treatment of chronic or low impact brain trauma